Back to Trades
Grant4
DEXCOM INC
DXCM
Total Value
$2.5M
Company Information
- Company Name
- DEXCOM INC
- Ticker Symbol
- DXCM
- CIK
- 0001093557
Insider Information
- Name
- SAYER KEVIN R
- Role
- Executive Chair, Director
- Location
- SAN DIEGO, CA
DirectorOfficer
Filing Details
- Filing Date
- Feb 2, 2026
- Transaction Date
- Jan 29, 2026
- Accession Number
- 0001093557-26-000009
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jan 29, 2026 | Common Stock | 71,218 | — | Grant/Award | — |
| Jan 29, 2026 | Common Stock | 34,257 | $73.36 | Tax Withholding | $2.5M |
Footnotes
- (F1)Represents shares issued to the Reporting Person upon vesting of performance-based restricted stock units (PSUs) granted to the Reporting Person on March 9, 2023, resulting from achievement of performance conditions under the PSUs.
- (F2)Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of PSUs and does not represent a sale by the Reporting Person.
- (F3)Included in this number are 138,091 unvested restricted stock units, 85,490 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 34,461 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 18,140 of which were granted on March 9, 2023 and shall vest through March 8, 2026.